Kohjin Bio Co., Ltd. (TYO:177A)

Japan · Delayed Price · Currency is JPY

1,219.00

+28.00 (2.35%)

Mar 6, 2026, 3:02 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Microbial Business	1.78B	1.66B	-	-	-
Microbial Business Growth	7.59%	-	-	-	-
Tissue Culture Business	2.27B	1.90B	-	-	-
Tissue Culture Business Growth	19.14%	-	-	-	-
Cell Processing Business	1.16B	1.21B	-	-	-
Cell Processing Business Growth	-4.46%	-	-	-	-
Biotechnology	-	-	4.74B	-	-
Total	5.21B	4.77B	4.74B	-	-
Total Growth	9.14%	0.59%	-	-	-

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	4.31B	4.13B	4.36B	-	-
Japan Growth	4.29%	-5.17%	-	-	-
Asia	896.52M	637.60M	385.34M	-	-
Asia Growth	40.61%	65.46%	-	-	-
Europe	373.00K	184.00K	50.00K	-	-
Europe Growth	102.72%	268.00%	-	-	-
Total	5.21B	4.77B	4.74B	-	-
Total Growth	9.14%	0.57%	-	-	-

Source: S&P Global Market Intelligence.